Arbutus Biopharma (ABUS) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ABUS is expected to report earnings to fall 12.73% to -9 cents per share on November 06

Arbutus Biopharma ABUS Stock Earnings Reports

Q3'24

Est.

$-0.10

Q2'24

Missed

by $0.01

Q1'24

Est.

$-0.10

Q4'23

Est.

$-0.12

Q3'23

Missed

by $0.01

The last earnings report on August 01 showed earnings per share of -10 cents, missing the estimate of -10 cents. With 950.12K shares outstanding, the current market capitalization sits at 723.04M.

View a ticker or compare two or three

Compare

ABUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ABUS
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ABUS (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

701 Veterans Circle

Phone

+1 267 469-0914

Employees

Web

http://www.arbutusbio.com